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Background: A major contributor to unfavorable outcome after traumatic brain injury
(TBI) is secondary brain injury. Low brain tissue oxygen tension (PbtO2) has shown
to be an independent predictor of unfavorable outcome. Although PbtO2 provides
clinicians with an understanding of the ischemic and non-ischemic derangements of
brain physiology, its value does not take into consideration systemic oxygenation that
can influence patients’ outcomes. This study analyses brain and systemic oxygenation
and a number of related indices in TBI patients: PbtO2, partial arterial oxygenation
pressure (PaO2), PbtO2/PaO2, ratio of PbtO2 to fraction of inspired oxygen (FiO2), and
PaO2/FiO2. The primary aim of this study was to identify independent risk factors for
cerebral hypoxia. Secondary goal was to determine whether any of these indices are
predictors of mortality outcome in TBI patients.
Materials and Methods: A single-centre retrospective cohort study of 70 TBI patients
admitted to the Neurocritical Care Unit (NCCU) at Cambridge University Hospital in
2014–2018 and undergoing advanced neuromonitoring including invasive PbtO2 was
conducted. Three hundred and three simultaneous measurements of PbtO2, PaO2,
PbtO2/PaO2, PbtO2/FiO2, PaO2/FiO2 were collected and mortality at discharge from
NCCU was considered as outcome. Generalized estimating equations were used to
analyse the longitudinal data.
Results: Our results showed PbtO2 of 28mmHg as threshold to define cerebral hypoxia.
PaO2/FiO2 found to be a strong and independent risk factor for cerebral hypoxia when
adjusting for confounding factor of intracranial pressure (ICP) with adjusted odds ratio of
1.78, 95% confidence interval of (1.10–2.87) and p-value = 0.019. With respect to TBI
outcome, compromised values of PbtO2, PbtO2/PaO2, PbtO2/FiO2, and PaO2/FiO2
were all independent predictors of mortality while considered individually and adjusting
for confounding factors of ICP, age, gender, and cerebral perfusion pressure (CPP).
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However, when considering all the compromised values together, only PaO2/FiO2
became an independent predictor of mortality with adjusted odds ratio of 3.47
(1.20–10.04) and p-value = 0.022.
Conclusions: Brain and Lung interaction in TBI patients is a complex interrelationship.
PaO2/FiO2 seems to be a major determinant of cerebral hypoxia and mortality. These
results confirm the importance of employing ventilator strategies to prevent cerebral
hypoxia and improve the outcome in TBI patients.
Keywords: mortality outcome, traumatic brain injury, cerebral oxygenation, partial arterial oxygen pressure, lung
injury, hypoxia threshold
INTRODUCTION
Traumatic brain injury (TBI) is a leading cause of death and
disability (1). A characteristic feature of TBI is a wide variation
in functional outcome (2). Clinicians treating patients with TBI
often make therapeutic decisions based on the assessment of
prognosis (3). Several studies have attempted to find parameters
that allow the clinicians to assess the risks and outcomes of
the patient after TBI. These include clinical and demographic
variables such as age, gender, race, Glasgow Coma Score (GCS),
which includes motor score and pupil reactivity, and cause of
injury (4).
A major contributor to unfavorable outcomes is secondary
brain damage which progresses hours or days after TBI (5). It is
widely accepted that causes of secondary injury include impaired
cerebral metabolism, hypoxia, and ischemia (5). Currently, severe
TBI care is centered on control of intracranial pressure (ICP)
and cerebral perfusion pressure (CPP), where invasive ICP
monitoring is the gold standard monitor (6). However, studies
have shown that cerebral hypoxia after severe TBI can occur
despite ICP and CPP being within normal ranges, and this note
should be taken into consideration when making a decision to
enhance treatment for ICP management (5–7). Furthermore,
cerebral hypoxia causing cellular metabolic dysfunction may
precede a rise in ICP, implying diffusion abnormalities rather
than abnormalities with perfusion (5).
Several studies suggested that cerebral hypoxia is also
an independent factor associated with unfavorable outcome
(7–9). Subsequently, brain tissue oxygen tension (PbtO2)
and microdialysis have been introduced in some institutions
as advanced brain monitoring methods to complement
ICP monitoring.
Although PbtO2 provides clinicians with an understanding
of the ischemic and non-ischemic derangements of brain
physiology (9, 10), there are some unanswered questions.
Firstly, it is not exactly known which parameters are the
major determinants of PbtO2. Hemoglobin, cerebral perfusion
pressure, and systemic oxygenation seem to have an important
role (10, 11); however, it is not clear which specific variable
has the predominant role in the occurrence of cerebral hypoxia.
Secondly, uncertainty exists regarding the critical threshold
that defines poor outcome and whether monitoring of PbtO2
influence the treatment and hence the outcome (12).
The most recent brain trauma foundation guidelines suggest
that “hypoxia detected by monitors is associated with worse
outcomes” (13). However, PbtO2 value alone does not take
into consideration systemic and ventilator parameters such as
partial arterial oxygen tension (PaO2), which are often crucial in
the neurocritical care population (14). We therefore conducted
a retrospective study, with the primary aim of indicating
the threshold of cerebral hypoxia and parameters that are
determinants of cerebral hypoxia. Our secondary goal was to
assess whether any of these indices (PbtO2, partial arterial
oxygenation pressure (PaO2), PbtO2/PaO2, ratio of PbtO2 to
fraction of inspired oxygen (FiO2), and PaO2/FiO2) based on the
relationship between cerebral tissue oxygenation and systemic
arterial oxygenation and the fraction of inspired oxygen, can be
useful for prognostication of mortality in TBI patients.
MATERIALS AND METHODS
This is a single-centre retrospective cohort study. The study
was approved by the relevant research ethic committee
(30REC97/291) for anonymized data recording.
Patient Inclusion, Data Collection, and
Management
Patients were identified using the EPIC system R© which contains
a database of all patients admitted to NCCU at Cambridge
University Hospitals between November 2014 and October 2018.
The patients included in this study were adult TBI requiring
advanced neuromonitoring with invasive ICP and PbtO2
captured using ICM+ R© brain monitoring software (Cambridge
Enterprise Ltd, Cambridge, UK; http://www.neurosurg.cam.ac.
uk/icmplus). ICP was monitored with an intraparenchymal
sensor (Codman ICP Micro-Sensor; Codman & Shurtleff,
Raynham, MA). Licox sensors (Codman Raynham, MA) were
inserted through a cranial access device (Technicam, Newton
Abbot, UK). The probe was inserted in the perilesional areas.
Arterial blood pressure (ABP) was zeroed at the level of the
middle cranial fossa (Baxter Healthcare Health Care Corp.
Cardio-Vascular Group, Irvine, CA). Arterial blood gases were
obtained through an invasive catheter in the radial artery
and concomitant PaO2 and PbtO2 values were recorded along
with fraction of inspired oxygen. The collected data was saved
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into a standardized and secure electronic spreadsheet using
Microsoft Excel 2013 R© (Redmond, WA, USA). The following
characteristics were manually collected and added to the dataset:
demographics of the patients, hemoglobin level (Hb), Glasgow
Coma Scale (GCS) at admission and mortality at discharge
from NCCU.
Patients were managed according to current TBI guidelines
and management protocol (15), based on a staircase approach
with increasing level of therapy including intravenous
sedation, neuromuscular paralysis, therapeutic hypothermia,
hyperosmolar therapy, cerebral spinal fluid diversion using
external ventricular drains, and surgical decompression. In
general, management endpoints include maintaining CPP
>60 mmHg and PbO2>20 mmHg in our unit (13, 15–17).
No withdrawal of life sustaining therapies was applied in the
study population.
Statistical Analysis
Our dataset consisted of instantaneous values of several variables
(ICP, CPP, Hb, FiO2) at time instances when measured
values for both PbtO2 and PaO2 were available. Due to
repeated simultaneous measurements of variables at different
time points and for different subjects (longitudinal data),
generalized estimating equations (an extension of generalized
linear models) with a covariance matrix structured by an
autoregressive model were employed (11). A p-value smaller
than 0.05 was considered as statistically significant. All the
analyses were conducted in Matlab R2017b (Mathworks, Natick,
MA). Throughout this paper, the term “episode” refers to each
simultaneous measurement of all variables. If PbtO2<Threshold
for an episode, then that episode is referred as “an episode with
compromised PbtO2” or “hypoxic.”
PbtO2 Threshold for Cerebral Hypoxia
In our study, we conducted two analyses to further investigate
the PbtO2 threshold: (A) We calculated the correlation of the
percentage of hypoxic episodes (defined as Pbto2<Threshold)
and the mortality outcome when Threshold value was changed
from 7 to 40 mmHg. (B) We also obtained the odds ratio
(OR) and its 95% confidence interval (CI) for mortality
detection by applying generalized estimating equations when
the compromised PbtO2 (dichotomized PbtO2<Threshold or
PbtO2≥Threshold) were entered to the model as input, mortality
outcome was considered as the response variable while adjusting
for confounding factors such as ICP, CPP, age and gender by
considering them as covariates (11).
Determinant of Cerebral Hypoxia
Our goal was to determine whether PaO2/FiO2 can be used
as a surrogate of PbtO2 and consequently as a predictor of
hypoxia. For this purpose, PbtO2 was considered as the response
variable. PaO2/FiO2 was entered into the model as continuous
input variable while adjusting for confounding factors such as
PaO2, CPP, and Hb by considering them as covariates in the
model. To find an optimal threshold on PaO2/FiO2 value to
indicate cerebral hypoxia, we plotted the mean and 95% CI of
PaO2/FiO2 values over dichotomized group of episodes: those
with compromised PbtO2 (PbtO2<Threshold), and those with
normal PbtO2 values (PbtO2≥Threshold) when Threshold was
changed over a range of 10–32 mmHg. We also calculated
the probability of the two-sample t-test that the difference
between average of compromised and normal PbtO2 episodes
is significant.
Predictors of Mortality
We aimed to identify those variables (among PaO2, PbtO2,
PbtO2/PaO2, PbtO2/FiO2, PaO2/FiO2) that were strong and
independent predictors of mortality. For this purpose, we found
the threshold value for each variable that can distinguish death
from survival outcomes by calculating the percentage of episodes
where the variable was smaller than the threshold value for
each patient. The mean and 95% CI of these percentages were
obtained and compared between patients who died and those
who survived. Then the most predictive (optimal) threshold
of mortality was identified as the threshold value where the
difference between the death and survival plots are maximized
in a statistically significant manner (when probability of t-test is
smaller than 0.05). Each variable was then dichotomized using
the obtained threshold value (variable< Threshold vs. variable
≥ Threshold) and entered into the model as input whereas the
mortality outcome was considered as the response variable. The
association of each dichotomized variable and mortality was also
adjusted for confounding factors ICP, CPP, age, and gender.
RESULTS
During the period of study, a total of 303 measurements from
70 patients fulfilled the inclusion criteria outlined previously.
TABLE 1 | Baseline data of study cohort.
Dead Survived P-value
N 13 57
Age (years) 63 ± 17 39 ± 18 <0.001*
Male (%) 76.9 70.2 0.608
GCS 4 (3–7.5) 14 (10.5–15) <0.001*
PaO2 112.0 ± 36.9 116.8 ± 30.3 0.328
FiO2 0.5 ± 0.2 0.4 ± 0.1 <0.001*
Pbto2 18.8 ± 8.8 26.0 ± 11.3 <0.001*
Pbto2/PaO2 0.18 ± 0.09 0.23 ± 0.11 <0.001*
Pbto2/FiO2 42.2 ± 25.2 75.6 ± 42.2 <0.001*
PaO2/Fio2 242.3 ± 85.2 326.0 ± 99.0 <0.001*
ICP 14.6 ± 7.9 9.6 ± 5.0 <0.001*
CPP 72.4 ± 12.7 76.5 ± 8.2 0.004*
Hb 9.56 ± 0.24 9.63 ± 0.11 0.002*
Number of measurements per patient 3 (1–6) 4 (2.75–6) 0.535
Numerical data are expressed as mean ± SD and compared with one-way ANOVA
with repeated measurements. Categorical data are expressed as number (percentage)
or median (IQR) and compared with chi-square test. N, number; GCS, Glasgow Coma
Scale; PaO2, partial pressure of oxygen; FiO2, inspired fraction of oxygen; PbtO2, brain
tissue oxygen tension; ICP, intracranial pressure; CPP, cerebral perfusion pressure; Hb,
Hemoglobin. *Statistically significant.
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FIGURE 1 | Identification of the optimal threshold on PbtO2 to define hypoxia: (A) Left-side vertical axis shows correlation values between the percentage of episodes
with compromised PbtO2 and the mortality outcome over all patients when the PbtO2 threshold (shown as horizontal axis) changed from 7 to 40 mmHg. Right-side
vertical axis displays the probability of the significance of the calculated correlation for each threshold value. (B) Left-side vertical axis displays odds ratio and its 95%
confidence interval for mortality detection by using dichotomized PbtO2 (PbtO2< Threshold or ≥Threshold) as the input of generalized estimating equations while
adjusting for confounding factors such as intracranial pressure (ICP), cerebral perfusion pressure (CPP), age and gender. The right-side vertical axis displays the
probability associated with calculated OR. The dashed green line represents the probability significance level of 0.05. So, any probability below the dashed green line
is statistically significant.
Table 1 summarizes the baseline data of the study cohort. The
mean age of the cohort was 43 ± 20. The average number of
repeated measurements per subject was 4.
Median admission GCS was 12.5 (6–15). Median number
of measurements per patient was 4 (2–6) and not significantly
different between those who survived and died. All other
variables except gender and PaO2 values were significantly
different between the two outcomes.
PbtO2 Threshold for Cerebral Hypoxia
Figure 1A presents the correlation plot along with probability
of its significance (right vertical axis) for when threshold value
changes from 7 to 40 mmHg. We observe that the statistically
significant correlation (p-value < 0.05) becomes more than 0.25
when hypoxic threshold is defined in the range of 20–31 mmHg.
Figure 1B presents Odds Ratio (OR) and its 95% Confidence
Interval (CI) for mortality detection along with its statistical
significance (probability on the right vertical axis). We observe
that the statistically significant odds ratio becomes equal or more
than 4 when PbtO2 threshold (and therefore to define hypoxia) is
in the range of 20–31 mmHg.
In our dataset both correlation and OR were maximized at
the threshold of 28 mmHg. Further grouping of the patients into
two age categories (those with age of ≥60 years old vs. those
younger than 60 years old) revealed that although the maximum
correlation for older subjects occurs at PbtO2 threshold of 28, this
threshold value decreases to 20 mmHg for the younger patients
(Figure 2).
From a total of 303 episodes of measurements, 186 episodes
had Pbto2<28. Among these, only 12 had ICP>20 and 6
episodes had CPP<60. Thus, prevalence of ICP elevation among
hypoxic episodes (12/186 or 6.1%) was comparable with general
prevalence of ICP elevation over all episodes (18/303 or 5.9%) (9).
Also, 60.6% of the hypoxic episodes (Pbto2 ≤ 28) had ICP value
lower than 20 and CPP value more than 60 mmHg.
Determinants of Cerebral Hypoxia
CPP and PbtO2 had a non-statistically significant correlation
of 0.1 (p = 0.063) considering the overall population. Hb and
PbtO2 had a statistically non-significant correlation of 0.14 (p =
0.084). PaO2/FiO2 revealed a statistically significant correlation
of 0.22 (p < 0.001) with brain tissue oxygenation. The results
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FIGURE 2 | Showcasing dependency of hypoxic PbtO2 threshold to subjects’ age: Correlation values between the percentage of episodes with compromised PbtO2
and the mortality outcome over patients when PbtO2 threshold (shown as horizontal axis) changed from 7 to 40 mmHg. Blue plot indicates the patients younger than
60 years old while red plot shows the correlation results for those who are 60 years old or older.
of generalized estimating equations revealed an independent
and strong linear correlation between brain oxygenation and
PaO2/FiO2 (adjusted p < 0.001).
Figure 3 shows the mean and 95% CI of PaO2/FiO2 over
dichotomized group of episodes based on PbtO2 threshold.
The right axis displays probability of two-sample t-test that the
difference between average of compromised and normal PbtO2
episodes is significant. We observe that if the hypoxia threshold
is defined in the acceptable range of 20–30 mmHg as discussed
before, then a PaO2/FiO2 in the range of 300–320 can result in
reasonable separation between compromised and normal Pbto2
episodes and consequently in identifying cerebral hypoxia. For
simplicity, in this work, we choose the middle of the range
as the optimal threshold of PaO2/FiO2 (PaO2/FiO2<310) to
indicate hypoxia for our dataset. Finally, analyzing independent
association between dichotomized PaO2/FiO2 (PaO2/FiO2< or
≥ 310) and hypoxia (defined as PbtO2 < 28) results revealed
that in fact, PaO2/FiO2 < 310 is an independent risk factor for
compromised PbtO2 in our dataset with adjusted odds ratio of
1.78, 95% confidence interval of (1.10–2.87) and p-value= 0.019
(Figure 3).
Predictors of Mortality
All variables except PaO2 showed statistically significant
correlation with mortality: PbtO2 (correlation = −0.24, p-value
< 0.001), PbtO2/PaO2 (correlation = −0.20, p-value < 0.001),
PbtO2/FiO2 (correlation = −0.30, p-value < 0.001), PaO2/FiO2
(correlation = −0.31, p-value < 0.001). Correlation value of
PaO2 with outcome was non-significant (correlation = −0.06,
p-value= 0.328).
Figure 4 displays the mean and 95% CI of the percentages
of compromised episodes for both death and survival outcomes.
Using these plots, for each variable, we identified the most
predictive (optimal) threshold of mortality as the threshold value
where the difference or separation between the death and survival
plots are maximized in a statistically significant manner. The
most predictive threshold on Pbto2, Pbto2/Pao2, Pbto2/Fio2, and
PaO2/FiO2 are 28, 0.27, 60, and 310, respectively.
Table 2 presents the adjusted odds ratios, its 95% CI and p-
values of death detection using the dichotomized version of each
variable by applying the optimal threshold we just obtained. We
observe that PbtO2<28, PbtO2/PaO2<0.27, PbtO2/FiO2<60,
and PaO2/FiO2<310 are each independent predictor ofmortality
when considered individually.
Finally, entering all these dichotomized variables as the
inputs of the model and mortality outcome as the output while
adjusting for confounding factors revealed that while each of
these dichotomized variables were individually an independent
predictor of mortality, when one considered all compromised
values together, then PaO2/FiO2 became the independent
predictor of mortality with adjusted odds ratio of 3.47 (1.20–
10.04) and p-value= 0.022.
DISCUSSION
Our results demonstrated that: (1) Cerebral hypoxic threshold
ranges from 20 to 31 mmHg; the optimal hypoxic threshold
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FIGURE 3 | Left-side vertical axis shows the average and 95% Confidence Interval (CI) of PaO2/FiO2 values for two groups of episodes: Those with compromised
PbtO2 values of PbtO2<Threshold (in red) and those with normal PbtO2 values of PbtO2≥Threshold (in blue). Right-side vertical axis indicates the probability of the
t-test that the average of PaO2/FiO2 values are significantly different between the normal (blue) and compromised episodes (red). The vertical axis displays the
Threshold values on PbtO2. The dashed green line represents the probability significance level of 0.05. So, whenever probability of the t-test (in black) is below the
dashed green line, PaO2/FiO2 values are significantly different between those episodes with compromised and normal PbtO2 values: This happened when PbtO2
Threshold is within the range of 20–30 mmHg. The average value of PaO2/FiO2 for when PbtO2 Threshold is within the range of 20–30 corresponds to 310 (The
dashed pink line). Thus, PaO2/FiO2 = 310 can be employed as the optimal threshold value on PaO2/FiO2 to define a hypoxic episode.
for patients older than or equal to 60 years old is 28 mmHg,
while this threshold decreases to 21 mmHg for those younger.
(2) PaO2/FiO2 is significantly correlated with PbtO2, whereas
CPP and Hb have a statistically non-significant correlation with
PbtO2. PaO2/FiO2<310 is an independent risk factor for cerebral
hypoxia. (3) PbtO2, PbtO2/PaO2, PbtO2/FiO2, and PaO2/FiO2
are each independent predictor of mortality. When considering
all these compromised values together PaO2/FiO2 becomes the
most independent predictor of morality.
Pathophysiology of brain tissue oxygenation is complicated
and dependent on several factors including oxygen delivery
(cerebral blood flow), arterial oxygen content, oxygen diffusion
from the capillary into the mitochondria and mitochondrial
oxygen consumption. Brain tissue oxygen is a good clinical
marker to identify ischemic and non-ischemic derangements of
brain physiology (12). Some studies showed that TBI patients
who did not survive, had lower PbtO2 values than those who did
survive (11, 12, 18, 19).
Although many have suggested PbtO2 of 20 mmHg as a
threshold associated with unfavorable outcome in brain injured
patients (8, 18), the optimal threshold of PbtO2 that correlates
with bad outcome is not clear and widely varies between
studies (20, 21). Meixensberg et al. (20) found no statistical
improvement in outcome at 6 months, when PbtO2 was
targeted above 10 mmHg. In a prospective study including TBI
patients (22), patients treated with ICP and brain tissue PbtO2
monitoring were compared with controls who had undergone
ICP monitoring alone, using a PbtO2 target of 25 mmHg. The
authors found a significantly reduced mortality rate (44 vs. 25%,
p < 0.05) in the group monitored with PbtO2. The recently
published BOOST-II study (23)-a randomized controlled trial
comparing patients undergoing treatment protocol based on
ICP+PbtO2 monitoring vs. ICP monitoring alone- found that
a management protocol based on PbtO2 (target 20 mmHg)
and ICP monitoring reduced the proportion of time with brain
tissue hypoxia after severe TBI (0.45 in ICP-only group, 0.16
in ICP+PbtO2 group; p < 0.0001) and had a trend toward
lower mortality and more favorable outcomes than ICP-only
treatment. The ongoing BOOST-III study (ClinicalTrials.gov:
NCT03754114) will aim to further clarify this issue.
Our results showed a higher threshold compared to the
aforementioned literature, but were in agreement with Eriksson
et al. (24), who found that the first 72 h of PbtO2<29 mmHg
were associated with higher mortality. These results challenge
the brain oxygenation threshold of 20 mmHg that has been
used conventionally and delineates a time for monitoring
PbtO2 that is predictive of outcome (5). However, we also
found that hypoxic PbtO2 threshold changes with age. Recent
evidence suggests that cerebrovascular autoregulation and ICP
are profoundly dependent on age (25). For example, cerebral
atrophy could buffer new pathological intracranial masses, which
can be linked to a lower incidence of intracranial hypertension
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FIGURE 4 | Left-side vertical axis shows the average and 95% confidence interval for the percentages of compromised episodes of a variable (when the variable<
Threshold) for two groups of patients: those who died (in red) and those who survived (in blue). The right-side vertical axis indicates the probability of the t-test that
percentage of compromised episodes is significantly different between those who died and survived. The dashed green line represents the probability significance
level of 0.05. So, whenever probability of the t-test (in black) is below the dashed green line, difference between death and survival is statistically significant. The pink
arrow displays where the best separation between the death and survival outcomes is achieved. This point can be used to obtain the optimal threshold value on each
of the following variables to indicate a hypoxic episode: (A) PbtO2, (B) PbtO2/PaO2, (C) PbtO2/FiO2, (D) PaO2/FiO2.
(26). Similarly, it is plausible that the need for higher target
of PbtO2 in the elderly population could be due to a lower
cerebrovascular reserve.
There are numerous factors that may affect PaO2 including
pH, temperature and the oxygen saturation of Hb (27). Among
these, CPP increase and consequent cerebral blood flow (CBF)
optimization seem to be one of the major determinants (28).
Rosenthal et al. (27) explored whether PbtO2 more closely
reflects variables related to cerebral oxygen diffusion or cerebral
oxygen delivery and metabolism. In this study, patients
underwent oxygen challenge (increase FiO2 100%), pressure
challenge (increase arterial blood pressure) and carbon dioxide
(CO2) challenge (hyperventilation). In multivariable analysis
adjusting for various variables of cerebral oxygen delivery and
metabolism, the only statistically significant relationship was
that between PbtO2 and the product of CBF and cerebral
arteriovenous oxygen tension difference (AVTO2), suggesting
a strong association between brain tissue oxygen tension and
diffusion of dissolved plasma oxygen across the blood-brain
barrier. In our cohort, all hypoxic episodes had low CPP,
although CPP< 60 did not prove to be an independent predictor
of hypoxia. The prevalence of ICP elevation among hypoxic
episodes (12/186, 6.1%) was comparable with general prevalence
of ICP elevation over all episodes (18/303, 5.9%). 60.6% of
the hypoxic episodes (PbtO2≤ 28) had ICP value lower than
20 and CPP value more than 60 mmHg, thus suggesting that
normal values of ICP and CPP do not necessarily prevent
hypoxia (22).
PbtO2 also depends on systemic oxygenation and ventilator
parameters (10). Assuming normal alveolar function, PaO2 has a
linear relationship with inspired oxygen (FiO2) (29). In patients
with acute respiratory distress syndrome (ARDS), the PaO2/FiO2
ratio whilst on standard ventilator settings, is an appropriate
tool to ensure correct categorization of patients with ARDS by
disease severity (30). There is further evidence showing strong
correlation between PbtO2 and FiO2 and a relationship between
PbtO2 and PaO2 (31–33).
In these settings, FiO2 can be easily controlled, but PaO2 may
be variable, therefore variations in PaO2 with FiO2 (as a result of
the various dependent factors described above) will have an effect
on the PbtO2, hence it will be dependent upon PaO2 fluctuations.
As a result, the absolute PbtO2 value may be better interpreted
whilst also considering the PaO2.
In the context of head injury, conventional physiology
states that if CBF is reduced below a defined ischaemic
threshold the affected areas of the brain must extract more
oxygen from the limited blood supply to maintain cerebral
metabolism (34). Through the use of oxygen-15 (15O) positron
emission tomography (PET), authors show that the mean oxygen
fraction (OEF) achieved significantly smaller OEF increases in
hypoxic regions compared with normoxic regions, with similar
falls in CBF (34). These findings imply that there may be
other mechanisms contributing to tissue hypoxia that cannot
be explained by classical physiological concepts relating to
macrovascular brain ischemia (34). Menon et al. used an end-
capillary oxygen tension (PvO2)—PbtO2 gradient in normoxic
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TABLE 2 | Odds Ratio (95% confidence interval) and p-value of death detection
using the dichotomized version of each variable (variable< Optimal Threshold).
Compromised value of the variable Odds ratio (95% CI) p-value
PbtO2<28 6.88 (2.13–22.23) 0.001*
PbtO2/PaO2<0.27 6.73 (2.14–21.14) 0.001*
PbtO2/FiO2<60 10.20 (3.64–28.61) <0.001*
PaO2/FiO2<310 4.54 (1.83–11.29) 0.001*
*Statistically significant.
and hypoxic areas of brain tissue in patients with TBI to
provide a measure of efficiency of microvascular oxygen delivery.
The authors found that hypoxic areas of brain exhibited large
diffusion gradients between tissue and end-capillary compared to
normoxic regions, despite similar reductions in CBF (34). This
can be explained by an increase in diffusion distance (increased
tissue path lengths for oxygen) due to endothelial swelling, patchy
microvascular collapse and peri-vascular edema. It is possible
that based on these findings, PbtO2/PaO2 and PbtO2/FiO2
ratio may be a better indicator to severity of brain injury than
absolute PbtO2.
The limitations of standalone PbtO2 monitoring was
recognized by Arikan et al. (35) who were able to calculate a
hypoxic threshold using a ratio of PbtO2/PaO2 suggesting that in
the absence of hypoxemia (low PaO2) and at a constant cerebral
metabolic rate of oxygen (CMRO2), ratios<0.10 indicated covert
hypoxia and a deficient delivery of oxygen into the brain.
PbtO2/PaO2 ratio was applied to investigate the oxygenation
status in tissue surrounding arterio-venous malformations
(AVMs) and in the distant brain during surgery to better
understand the perfusion pressure breakthrough phenomenon
(36). In a cohort of 22 patients with supratentorial AVMs and 16
patients with cerebral aneurysm as controls, PbtO2/PaO2 ratio
showed to be a better indicator than absolute PbtO2 in detecting
intraoperative hypoxia in the margins of AVMs and in the distal
ipsilateral brain. In our study, we found that PbtO2/PaO2<0.27
is an independent predictor of mortality. Our results confirm
previous results but they also add new insight because of
the higher number of patients and for the application of this
index in traumatic brain injured patients and its correlation
with outcome.
PbtO2/FiO2 ratio has never been studied so far, but- for the
above mentioned reasons- it is plausible that it could be able
to predict the severity of systemic and cerebral oxygenation
impairment and could be potentially useful as part of the
decision making for escalation of treatment after TBI (6). Finally,
the PaO2/FiO2 threshold for mortality is consistent with the
PaO2/FiO2 definition of ARDS and seems to be the most
independent predictor ofmortality comparing to other ratio, thus
suggesting that the role of systemic oxygenation and mechanical
ventilation is fundamental in brain injured patients (37–39).
Limitations of the Study
The present study has several limitations that can interfere with
the generalization of the results. First, this is a retrospective
study and thus, some clinical data regarding the specific type
of TBI injury and neurosurgical interventions were lacking.
Second, the population studied is heterogeneous with different
clinical presentations (as for GCS). Third, the study sample
size is small both in terms of number of subjects and
number of measurements per patient. Fourth, our dataset
consisted of variable values at when the Pbto2 and Pao2
measurements were available. Conducting a prospective study
while addressing these issues are needed for further validation of
our findings.
CONCLUSION
Among the determinants of cerebral oxygenation, systemic
oxygenation seems to have the greater role. Therefore,
appropriate mechanical ventilation to achieve appropriate
oxygen targets is fundamental for the management of TBI
patients. The critical threshold of PbtO2 could be related to
patient’s age; therefore, the threshold of cerebral oxygenation
to consider treatment escalation should be made considering
patients’ specific and individualized need.
Indices such as the PbtO2/PaO2, PbtO2/FiO2, and PaO2/FiO2
ratios can be potentially used to discriminate patients at risk of
mortality in TBI patients. We therefore believe that the inclusion
of these indices may reflect the interrelationship between
pathologies in the brain and lung in a more comprehensive
fashion. The future work can include further validations of these
findings in a prospective study.
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